General Hospital Psychiatry
Volume 32, Issue 1 , Pages 57-65 , January 2010

Is the personality characteristic “impulsive sensation seeking” correlated to differences in current smoking between ulcerative colitis and Crohn's disease patients?

  • Thomas Hyphantis, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Medical School, University of Ioannina, Ioannina 45110, Greece
    • Psychiatry Research Group, Medical School, University of Manchester, Manchester M13 9WL, UK
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Medical School, University of Ioannina, Ioannina 45110, Greece. Tel.: +30 26510 97322.
    • ,
  • Katerina Antoniou, Ph.D.

      Affiliations

    • Department of Pharmacology, Medical School, University of Ioannina, Ioannina 45110, Greece
    • ,
  • Barbara Tomenson, M.Sc.

      Affiliations

    • Psychiatry Research Group, Medical School, University of Manchester, Manchester M13 9WL, UK
    • ,
  • Epameinondas Tsianos, M.D., Ph.D.

      Affiliations

    • First Division of Internal Medicine and Hepato-Gastroenterology Unit, Medical School, University of Ioannina, Ioannina 45110, Greece
    • ,
  • Venetsanos Mavreas, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Medical School, University of Ioannina, Ioannina 45110, Greece
    • ,
  • Francis Creed, M.D., F.Med.Sci.

      Affiliations

    • Psychiatry Research Group, Medical School, University of Manchester, Manchester M13 9WL, UK

Received 10 June 2009 ,Accepted 8 September 2009.

References 

  1. Birrenbach T, Böcker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis. 2004;10(6):848–859
  2. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly?. World J Gastroenterol. 2007;13(46):6134–6139
  3. Brignola C, Belloli C, Ardizzone S, et al. The relationship between heritability and smoking habits in Crohn's disease: Italian Cooperative Study Group. Am J Gastroenterol. 2000;95:3171–3175
  4. Bridger S, Lee JC, Bjarnason I, et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut. 2002;51:21–25
  5. Sternberg EM, Chrousos GP, Wilder RL, et al. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117:854–866
  6. Sternberg EM. Neuroendocrine factors in susceptibility to inflammatory disease: focus on the hypothalamic-pituitary-adrenal axis. Horm Res. 1995;43:159–161
  7. Munafò MR, Zetteler JI, Clark TG. Personality and smoking status: a meta-analysis. Nicotine Tob Res. 2007;9(3):405–413
  8. Zuckerman M, Neeb M. Demographic influences in sensation seeking and expressions of sensation seeking in religion, smoking, and driving habits. Pers Individ Dif. 1980;(1):197–206
  9. Goldring JF, Harper GT, Brent-Smith H. Personality, drinking and drug-taking correlates of cigarette smoking. Pers Individ Dif. 1983;(4):703–706
  10. Zuckerman M, Ball S, Black J. Influences of sensation seeking, gender, risk appraisal, and situational motivation on smoking. Addict Behav. 1990;15(3):209–220
  11. Barrett SM, Standen PJ, Lee AS, et al. Personality, smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1996;8(7):651–655
  12. Zuckerman M. Sensation seeking: beyond the optimal level of arousal. Hillsdale (NJ): Erlbaum; 1979;
  13. Zuckerman M. Behavioral expressions and biosocial bases of sensation seeking. New York: Cambridge University Press; 1994;
  14. Zuckerman M, Kuhlman DM. Personality and risk-taking: common biosocial factors. J Pers. 2000;68(6):999–1029
  15. Zuckerman M, Kuhlman DM, Teta P, et al. A comparison of three structural models of personality: the big three, the big five, and the alternative five. J Pers Soc Psychol. 1993;(65):757–768
  16. Zuckerman M. Impulsive unsocialized sensation seeking: the biological foundations of a basic dimension of personality. In:  Bates JE,  Wachs TD editor. Temperament: individual differences at the interface of biology and behaviour. Washington, DC: American Psychological Association; 1994;p. 219–255
  17. Zuckerman M. Zuckerman–Kuhlman Personality Questionnaire (ZKPQ): an alternative five-factorial model. In:  de Raad B,  Perugini M editor. Big five assessment. Gottingen, Germany: Hogrefe & Huber; 2002;p. 377–396
  18. Mitchell SH. Measuring impulsivity and modeling its association with cigarette smoking. Behav Cogn Neurosci Rev. 2004;3(4):261–275
  19. Reuter M, Netter P. The influence of personality on nicotine craving: a hierarchical multivariate statistical prediction model. Neuropsychobiology. 2001;44(1):47–53
  20. Reuter M, Netter P, Rogausch A, et al. The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects. Hum Psychopharmacol. 2002;17(5):213–224
  21. Benowitz NL. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med. 2008;121(4 Suppl 1):S3–S10
  22. Nides M. Update on pharmacologic options for smoking cessation treatment. Am J Med. 2008;121(4 Suppl 1):S20–S31
  23. Le Foll B, Forget B, Aubin HJ, et al. Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addict Biol. 2008;13(2):239–252
  24. Garwood CL, Potts LA. Emerging pharmacotherapies for smoking cessation. Am J Health Syst Pharm. 2007;64(16):1693–1698
  25. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9:139–145
  26. Morris PL, Goldberg RJ. Validity of the 28-item General Health Questionnaire in hospitalized gastroenterology patients. Psychosomatics. 1989;30(3):290–295
  27. Garyfallos G, Karastergiou A, Adamopoulou A, et al. Greek version of the General Health Questionnaire: accuracy of translation and validity. Acta Psychiatr Scand. 1991;84:371–378
  28. Rossier J, Aluja A, Garcia LF, et al. The cross-cultural generalizability of Zuckerman's alternative five-factor model of personality. J Pers Assess. 2007;89(2):188–196
  29. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom Test for Nicotine Dependence. A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;(91):1119–1127
  30. Diaz FJ, Jane M, Salto E, et al. A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry. 2005;39(3):161–168
  31. Hilsden RJ, Hodgins D, Czechowsky D, et al. Attitudes toward smoking and smoking behaviors of patients with Crohn's disease. Am J Gastroenterol. 2001;96(6):1849–1853
  32. Piper ME, McCarthy DE, Baker TB. Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res. 2006;8(3):339–351
  33. Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1991;
  34. Hyphantis TN, Triantafillidis JK, Pappa S, et al. Defense mechanisms in inflammatory bowel disease. J Gastroenterol. 2005;40:24–30
  35. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59(10):877–883
  36. Kraemer H.C., Frank E., Kupfer D.J., Moderators of treatment outcomes: clinical, research, and policy importance. JAMA;296(10):1286-1289.
  37. Miles J, Shevlin M. Moderator and mediator analysis. In:  Miles J,  Shelvin M editor. Applying regression and correlation. London: Sage Publications; 2003;p. 165–191
  38. Fagerström KO, Kunze M, Schoberberger R, et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 1996;5(1):52–56
  39. Vardavas CI, Kafatos AG. Smoking policy and prevalence in Greece: an overview. Eur J Public Health. 2007;17(2):211–213
  40. Gazzard BG, Price HL, Libby GW, et al. The social toll of Crohn's disease. BMJ. 1978;2:1117–1119
  41. Robertson DAF, Ray J, Diamond I, et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut. 1989;30:623–626
  42. Addolorato G, Capristo E, Stefannini GF, et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity and nutritional status. Scand J Gastroenterol. 1997;32:1013–1021
  43. Heltzer JE, Stillings WA, Chammas S, et al. A controlled study of the association between ulcerative colitis and psychiatric illness. Dig Dis Sci. 1982;27(6):513–518
  44. Tocci A, Lepre L, Liotta G, et al. Familial and psychological risk factors of ulcerative colitis. Ital J Gastroenterol Hepatol. 1997;29:395–398
  45. Häuser W, Stallmach A, Caspary WF, et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther. 2007;25(5):569–578
  46. Zhang SJ, Huang LH, Wen YL, et al. Impact of personality and coping mechanisms on health related quality of life in liver transplantation recipients. Hepatobiliary Pancreat Dis Int. 2005;4(3):356–359
  47. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50(12):975–990
  48. Zuckerman M. Sensation seeking. In:  Zuckerman M editors. Sensation seeking and risky behavior. Washington, DC: American Psychological Association; 2007;p. 3–51
  49. Vidal A, Gómez-Gil E, Sans M, et al. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis. 2008;14(7):977–983
  50. Spielberger CD, Jacobs GA. Personality and smoking behavior. J Pers Assess. 1982;46(4):396–403
  51. Doran N, Spring B, McChargue D, et al. Impulsivity and smoking relapse. Nicotine Tob Res. 2004;6(4):641–647
  52. Corrigall WA, Franklin KB, Coen KM, et al. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 1990;107:285–289
  53. Sziraki I, Sershen H, Benuck M, et al. Receptor systems participating in nicotine-specific effects. Neurochem Int. 1998;33:445–457
  54. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev. 2007;56(2):283–321
  55. Volkow ND, Fowler JS, Wang GJ. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol. 1999;13(4):337–345
  56. Lipkus IM, Barefoot JC, Williams RB, Siegler IC. Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study. Health Psychol. 1994;13(2):149–155
  57. Mitchell SH. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl). 1999;146(4):455–464
  58. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther. 2005;21(8):921–931
  59. Cosnes J, Beaugerie L, Carbonnel F, et al. Decreased severity of Crohn's disease after smoking cessation. Preliminary results of a prospective intervention study. Gastroenterology. 2000;118:A870
  60. Zutshi M, Hull TL, Hammel J. Crohn's disease: a patient's perspective. Int J Colorectal Dis. 2007;22(12):1437–1444
  61. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001;120(5):1093–1099

PII: S0163-8343(09)00176-5

doi: 10.1016/j.genhosppsych.2009.09.002

General Hospital Psychiatry
Volume 32, Issue 1 , Pages 57-65 , January 2010

Article Tools

* Image Usage & Resolution